(Q50758266)

18 March 2018

title

Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. (English)

1 reference

18 March 2018

1

C Peters

1 reference

18 March 2018

author name string

M Minkov

2

1 reference

18 March 2018

H Gadner

3

1 reference

18 March 2018

T Klingebiel

4

1 reference

18 March 2018

J Vossen

5

1 reference

18 March 2018

F Locatelli

6

1 reference

18 March 2018

J Cornish

7

1 reference

18 March 2018

J Ortega

8

1 reference

18 March 2018

A Bekasi

9

1 reference

18 March 2018

G Souillet

10

1 reference

18 March 2018

J Stary

11

1 reference

18 March 2018

D Niethammer

12

1 reference

18 March 2018

European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases

13

1 reference

18 March 2018

International BFM Study Group--Subcommittee Bone Marrow Transplantation (IBFM-SG)

14

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

18 March 2018

Bone Marrow Transplantation

published in

1 reference

18 March 2018

volume

26

1 reference

18 March 2018

issue

4

1 reference

18 March 2018

page(s)

405-411

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702524

exact match

0 references

cites work

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

An influence diagram for assessing GVHD prophylaxis after bone marrow transplantation in children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Practical aspects in the use of cyclosporin in paediatric nephrology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Pulse glucocorticoid therapy. The 'big shot' revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

PUVA therapy for chronic cutaneous graft-vs-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Correlation between low CSA plasma concentration and severity of acute GvHD in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702524

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702524

1 reference

18 March 2018

1 reference

18 March 2018